Results for
""Receptors, Purinergic""[mesh_terms]

The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy.

Chifei Kang, Luyu Liu, Chengyu Wu, Lingyun Li, Xiao Jia, Wendi Xie, Siyu Chen, Xinying Wu, Huaxiao Zheng, Jingxin Liu, Rongsong Li, Bin Zeng

Frontiers in immunology 2023;14():1111369

Purinergic signaling and the functioning of the nervous system cells.

Kamila Puchałowicz, Irena Baranowska-Bosiacka, Violetta Dziedziejko, Dariusz Chlubek

Cellular & molecular biology letters 2016;20(5):867-918

Current knowledge on the role of P2Y receptors in cardioprotection against ischemia-reperfusion.

Zoubir Djerada, Catherine Feliu, Vincent Richard, Hervé Millart

Pharmacological research 2018;118():5-18

Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells.

K Wareham, C Vial, R C E Wykes, P Bradding, E P Seward

British journal of pharmacology 2010;157(7):1215-24

Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells.

G Tonon, G A Jamieson, R Dalal, X Luo, W Chen, N J Greco

Blood 2001;98(1):100-7

Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding.

A D Michel, L J Chambers, W C Clay, J P Condreay, D S Walter, I P Chessell

British journal of pharmacology 2007;151(1):103-14

Intracellular calcium homeostasis in patients with early stages of chronic kidney disease: effects of vitamin D3 supplementation.

Ingrid Lajdova, Viera Spustova, Adrian Oksa, Alzbeta Chorvatova, Dusan Chorvat, Rastislav Dzurik

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;24(11):3376-81

Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane.

Vahideh Rabani, Damien Montange, Nicolas Meneveau, Siamak Davani

Platelets 2018;29(7):709-715

Stimulation of platelet P2Y receptors by different endogenous nucleotides leads to functional selectivity via biased signalling.

Kate L Arkless, Dingxin Pan, Manu Shankar-Hari, Richard T Amison, Clive P Page, Khondaker Miraz Rahman, Simon C Pitchford

British journal of pharmacology 2024;181(4):564-579

Role of astrocyte purinergic signaling in epilepsy.

Ljiljana Nikolic, Paola Nobili, Weida Shen, Etienne Audinat

Glia 2021;68(9):1677-1691

A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation.

Jeremy E Purvis, Manash S Chatterjee, Lawrence F Brass, Scott L Diamond

Blood 2008;112(10):4069-79

ENTPDases from Pathogenic Trypanosomatids and Purinergic Signaling: Shedding Light towards Biotechnological Applications.

Nancy da Rocha Torres, Walmir da Silva, Joice de Melo Agripino, Victor Hugo Ferraz da Silva, Anna Cláudia Alves de Souza, Isadora Cunha Ribeiro, Tatiana Aparecida de Oliveira, Luciana Angelo de Souza, Lethicia Kelly Ramos Andrade, João Victor Badaró de Moraes, Marcel Arruda Diogo, Raíssa Barbosa de Castro, Marcelo Depolo Polêto, Luis Carlos Crocco Afonso, Juliana Lopes Rangel Fietto

Current topics in medicinal chemistry 2021;21(3):213-226

Purinergic receptors in airway epithelia.

Eduardo R Lazarowski, Richard C Boucher

Current opinion in pharmacology 2009;9(3):262-7

Druggable site near the upper vestibule determines the high affinity and P2X3 homotrimer selectivity of sivopixant/S-600918 and its analogue DDTPA.

Meng Zhang, Yun-Tao Lei, Ye Yu, Yun Tian, Michael X Zhu, Peng Cao, Changzhu Li, Xiao-Na Yang, Ming Li, Dong-Ping Wang

British journal of pharmacology 2024;181(8):1203-1220